Can a balance-training program help brain injury survivors walk safer and live better?

NCT ID NCT07696663

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

This trial tests whether a rehabilitation program that targets different aspects of balance can improve balance, mobility, walking, and quality of life in adults with acquired brain injury (from stroke, trauma, or other causes). Participants are randomly assigned to either the balance program or standard physiotherapy for 12 weeks. Researchers measure changes in balance, mobility, fall risk, and quality of life right after treatment and again 6 and 12 weeks later.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Multimodal Balance Rehabilitation Program
What this could lead to
If effective, this program could become a standard rehab approach to improve balance and reduce fall risk in people with brain injury.
What could go wrong
This is a small, early-stage trial with 68 participants, so results may not apply broadly. The program is intensive (5 sessions/week for 12 weeks), which may be hard to maintain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACQUIRED BRAIN INJURY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Centro de Referencia Estatal de Atención al Daño Cerebral (CEADAC)

    Madrid, Madrid, 28031, Spain

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.